AHA Coding Clinic® for HCPCS - 2022 Issue 4; For Your Information

Updates to Emergency Use Authorizations for COVID-19 vaccines

The U.S. Food and Drug Administration (FDA) has authorized several amended versions of its emergency use authorizations (EUA) for the administration of COVID-19 vaccines for the prevention of COVID-19 infection. Effective Aug. 19, 2022, the EUA for the administration of the Novavax COVID-19 vaccine adjuvanted, two dose primary series, was amended to include all patients 12 through 17 years of age. Effective Aug. 31, 2022, the EUA for the administration of the Pfizer-BioNTech bivalent vaccine was amended to authorize the vaccine for patients 12 years and older. The Moderna bivalent vaccine EUA was expanded and authorized...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.

Thank you for choosing Find-A-Code, please Sign In to remove ads.